Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 21;66(6):e0057922.
doi: 10.1128/aac.00579-22. Epub 2022 May 11.

Why Bother? Lab Monitoring in Beta-Lactam Outpatient Parenteral Antimicrobial Therapy

Kelsea Zukauckas  1 , Russell J Benefield  1 , Michael Newman  2 , Laura Certain  3
Affiliations

Why Bother? Lab Monitoring in Beta-Lactam Outpatient Parenteral Antimicrobial Therapy

Kelsea Zukauckas et al. Antimicrob Agents Chemother. .
No abstract available

Keywords: OPAT; adverse drug reactions; beta-lactam.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIG 1
FIG 1
Waffle chart of patient population. One circle, 1%.
See this image and copyright information in PMC

References

    1. Shah A, Norris A (ed). 2016. OPAT eHandbook. https://www.idsociety.org/opat-ehandbook/. Accessed 3 August 2019.
    1. Norris AH, Shrestha NK, Allison GM, Keller SC, Bhavan KP, Zurlo JJ, Hersh AL, Gorski LA, Bosso JA, Rathore MH, Arrieta A, Petrak RM, Shah A, Brown RB, Knight SL, Umscheid CA. 2019. 2018 Infectious Diseases Society of America clinical practice guideline for the management of outpatient parenteral antimicrobial therapy. Clin Infect Dis 68:e1–e35. doi:10.1093/cid/ciy745. - DOI - PubMed
    1. Huck D, Ginsberg JP, Gordon SM, Nowacki AS, Rehm SJ, Shrestha NK. 2014. Association of laboratory test result availability and rehospitalizations in an outpatient parenteral antimicrobial therapy programme. J Antimicrob Chemother 69:228–233. doi:10.1093/jac/dkt303. - DOI - PubMed
    1. Keller SC, Ciuffetelli D, Bilker W, Norris A, Timko D, Rosen A, Myers JS, Hines J, Metlay J. 2013. The impact of an infectious diseases transition service on the care of outpatients on parenteral antimicrobial therapy. J Pharm Technol 29:205–214. doi:10.1177/8755122513500922. - DOI - PMC - PubMed
    1. Muldoon EG, Switkowski K, Tice A, Snydman DR, Allison GM. 2015. A national survey of infectious disease practitioners on their use of outpatient parenteral antimicrobial therapy (OPAT). Infect Dis (Lond) 47:39–45. doi:10.3109/00365548.2014.967290. - DOI - PubMed

LinkOut - more resources